Treatment News

Home Treatment News
Treatment News

Flu Continues Sweep of State

Between January 31st and February 6th, more than 350 patients were hospitalized in Oklahoma with positive flu testing.  In total, Oklahoma hospitals have experienced...

FDA Approves Domestic Manufacture of Imaging Isotope

The FDA has announced the approval of RadioGenix, a domestic manufacturing system, which produces Technetium-99m which is used in medical imaging.  Technetium-99m is used...

Zytiga Patent Struck, Door Opened for Generic Prostate Cancer Drugs

The United State Patent and Trademark Office on Tuesday, January 17, 2018, invalidated the patent held by Johnson & Johnson (via Janssen Oncology, Inc.)...

FDA Issues Advisory Related to Gout Medication — Febuxostat (Uloric)

The FDA on Nov. 15, 2017, issued a public alert advising that the drug febuxostat (Uloric), used by many for treatment of gout may...

Medicare Quality Measure Ratings for Oklahoma Nursing Homes

The Centers for Medicare and Medicaid Services (CMS) released data in October rating nursing homes and other long-term care facilities and skilled nursing facilities. The...

Medicare Staff Ratings for Oklahoma Nursing Homes

The Centers for Medicare and Medicaid Services (CMS) released data in October rating nursing homes and other long-term care facilities and skilled nursing facilities. The...

Medicare Health Inspection Ratings for Oklahoma Nursing Homes

The Centers for Medicare and Medicaid Services (CMS) released data in October rating nursing homes and other long-term care facilities and skilled nursing facilities. The...

Medicare Overall (5-Star) Rating for Oklahoma Nursing Homes

The Centers for Medicare and Medicaid Services (CMS) released data in October rating nursing homes and other long-term care facilities and skilled nursing facilities. The...

Oklahoma Nursing Homes Strive for High Star Ratings Amid Evolving Regulatory...

The Centers for Medicare and Medicaid Services (CMS) released data in October rating nursing homes and other long-term care facilities and skilled nursing facilities. The...

FDA Gives Nod to Calquence for Mantle Cell Lymphoma Treatment

The U.S. Food and Drug Administration on October 31, 2017, approved limited use of Calquence for treatment of adults suffering from mantle cell lymphoma. To...